Tiankang Bio plans to list its animal vaccine business separately on the Beijing Stock Exchange
May 1, 2025
Source: drugdu
71
April 30th, regarding the company's business integration planning, Tiankang Bio said during an institutional survey on April 29 that the company's business involves feed, pig farming, animal vaccines, agricultural products, etc., which are all part of the livestock industry chain, and there is a certain degree of synergy between the various business segments.
Among them, the animal vaccine business has a relatively high technical content and requires high technological innovation and research and development. The company plans to list this business separately on the Beijing Stock Exchange to obtain more resource support. The correlation between feed and breeding businesses is very high, and the integration of these two businesses will become higher and higher in the future, and may be integrated. The agricultural products business mainly provides raw material supporting services for the feed business.
https://finance.eastmoney.com/a/202504303394308111.html
By editor
Copyright©2025 Ddu. All rights reserved.
Read more on
- Bodybuilding Linked To Sudden Cardiac Deaths May 23, 2025
- Deaths Waiting For Lung Donation Have Dropped Under New Guidelines May 23, 2025
- InnoCare Pharma’s application for marketing approval of Tancitumomab for injection May 23, 2025
- MicuRx Pharmaceuticals’ new drug application for contezolizumab sodium injection has been accepted May 23, 2025
- Pfizer acquires bispecific antibodies from 3SBio for $6.05 billion May 23, 2025
your submission has already been received.
OK
Subscribe
Please enter a valid Email address！
Submit
The most relevant industry news & insight will be sent to you every two weeks.
